• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FLEXIMA BILIARY; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FLEXIMA BILIARY; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M00539260
Device Problems Break (1069); Positioning Failure (1158); Use of Device Problem (1670); Material Deformation (2976); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/17/2024
Event Type  malfunction  
Event Description
It was reported to boston scientific corporation that a flexima biliary preloaded stent was to be implanted in the biliary tract for stent placement during an endoscopic retrograde cholangiopancreatography (ercp) procedure performed on (b)(6) 2024.During the procedure, the touhy borst was broken, and the stent could not be deployed.The procedure was completed with another of the same device.There were no patient complications reported as a result of this event, and the patient's condition after the procedure was reported to be stable.Note: it was reported that the guidewire was inside the patient during the attempted deployment.However, the flexima biliary stent with delivery system instructions for use (ifu) states, "to deploy the stent, loosen the tuohy-borst adapter slightly and pull on the guide catheter luer-lok hub and guidewire.Hold the outer positioner stationary, while gently retracting the inner guide catheter and guidewire.Endoscopically monitor the stent position.Warning: if the guidewire is not completely retracted into the delivery system, the stent can not be fully deployed." the physician did not follow the steps cited in the ifu.This event has been deemed an mdr-reportable event based on the investigation finding of the guide catheter break.Please see block h10 for the full investigation details.
 
Manufacturer Narrative
Block h6: imdrf device code a0401 captures the reportable investigation finding of a guide catheter break.Block h10: the flexima biliary preloaded stent and delivery system were returned for analysis along with a non-boston scientific guidewire.The touhy borst was not received for analysis.Visual inspection found that the stent was still attached to the delivery system, but the guide catheter had detached, was kinked and buckled, and was stuck to the non-boston scientific guidewire.No other damages were noted with the stent or delivery system.Product analysis confirmed the reported events of stent failure to deploy and device user error; however, the reported event of a touhy borst breakage was not confirmed because it was not returned for analysis.A labeling review was performed, and from the information available, this device was used in a manner inconsistent with the instructions for use (ifu)/product label.It was reported that the guidewire was inside the patient during the attempted deployment.However, the flexima biliary stent with delivery system instructions for use (ifu) states, "to deploy the stent, loosen the tuohy-borst adapter slightly and pull on the guide catheter luer-lok hub and guidewire.Hold the outer positioner stationary while gently retracting the inner guide catheter and guidewire.Endoscopically monitor the stent position.Warning: if the guidewire is not completely retracted into the delivery system, the stent cannot be fully deployed." thus, the user did not follow the manufacturer's instructions.The investigation further concluded that the inability of the stent to be deployed and the additional investigation findings of guide catheter buckled, detached, and kinked were most likely due to procedural factors such as lesion characteristics, the handling of the device, and the technique used by the physician (force applied).Therefore, taking all available information into consideration the overall root cause of the reported event is adverse event related to procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLEXIMA BILIARY
Type of Device
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key18912919
MDR Text Key337766226
Report Number3005099803-2024-01056
Device Sequence Number1
Product Code FGE
UDI-Device Identifier08714729162575
UDI-Public08714729162575
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K965147
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 03/15/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/15/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberM00539260
Device Catalogue Number3926
Device Lot Number0032467392
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/13/2024
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/22/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/20/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age38 YR
Patient Weight58 KG
-
-